<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969133</url>
  </required_header>
  <id_info>
    <org_study_id>2021/571</org_study_id>
    <nct_id>NCT04969133</nct_id>
  </id_info>
  <brief_title>TAP Block Versus Local Anesthesia Wound Infiltration for Postoperative Pain Relief After Appendicectomy in Children</brief_title>
  <acronym>PABLO</acronym>
  <official_title>TAP Block Versus Local Anesthesia Infiltration at Wound Site for Postoperative Pain Relief After Laparoscopic Appendicectomy in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      When performing laparoscopic appendectomy in children, regional anesthetic techniques are&#xD;
      rou-tinely used concomitantly with general anesthesia. These techniques include local&#xD;
      infiltration of the trocar wounds or transverse abdominal plane block (TAP block). In 2018, a&#xD;
      position paper of the European Society of Pediatric Anaesthesiology advised for TAP block&#xD;
      over local infiltration of the trocar wounds. However, there is no randomized study comparing&#xD;
      both techniques in children. The aim of this study is to compare morphine consumption during&#xD;
      the first 24 postoperative hours in children undergoing laparoscopic appendectomy and&#xD;
      randomly allocated to either local infiltration of the trocar wounds or TAP block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double blind randomized study with two parallel groups. Children between 3 and 15&#xD;
      years of age with indication of laparoscopic appendectomy will be approached for inclusion in&#xD;
      this trial. Informed consent will be asked for from the parents and the child. Before&#xD;
      surgery, patients will be randomized to either local infiltration of the trocar wounds or TAP&#xD;
      block using sequentially numbered sealed envelope each with a random number inside. Patients&#xD;
      with peritonitis will be excluded. A standardized analgesia protocol within the first 24&#xD;
      post-operative hours will be applied and the primary outcome is nalbuphine consumption during&#xD;
      this time frame. Secondary outcomes include postoperative pain (FLACC assessment tool) and&#xD;
      postoperative nausea and vomiting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 30, 2021</start_date>
  <completion_date type="Anticipated">May 25, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cumulative dose of nalbuphine in the 24 first hours post surgery</measure>
    <time_frame>24 hours</time_frame>
    <description>recording in mg/kg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cumulative dose of nalbuphine H0-H12 post surgery</measure>
    <time_frame>from beginning to 12th hour</time_frame>
    <description>recording in mg/kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative dose of nalbuphine H13-H24 post surgery</measure>
    <time_frame>From 13th hour to 24th hour</time_frame>
    <description>recording in mg/kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC analgesia score at H1 H2 H6 H12 H24</measure>
    <time_frame>FLACC score will be performed from awakenig to 24 hours post surgery</time_frame>
    <description>Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC score mean</measure>
    <time_frame>FLACC score will be performed from awakenig to 24 hours surgery</time_frame>
    <description>Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>individual variations of FLACC score</measure>
    <time_frame>FLACC score will be performed from awakenig to 24 hours surgery</time_frame>
    <description>Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>timing of first injection of nalbuphine</measure>
    <time_frame>in the first 24 post operative hours</time_frame>
    <description>recording date and time of first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of post operative nausea and vomiting</measure>
    <time_frame>in the first 24 post operative hours</time_frame>
    <description>recording the incidence post operative nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>timing of first standing up</measure>
    <time_frame>in the first 24 post operative hours</time_frame>
    <description>recording date and time of first standing up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>in the first 24 post operative hours</time_frame>
    <description>adverse event monitoring</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Appendicitis Acute</condition>
  <condition>Pediatrics</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transverse abdominal block is realisated at the beginning of the surgery with ultrasound guided technique with levobupivacaine 2.5mg/mL, 0.3mL/kg each side.&#xD;
The patient receives usual analgesia protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local infiltration of the trocar wounds</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>local infiltration of the trocar wounds is realisated at the end of the surgery by the surgeon with levobupivacaine 2.5mg/mL 0.6mL/kg distributed in each trocar opening.&#xD;
The patient receives usual analgesia protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine Hydrochloride 2.5 MG/ML</intervention_name>
    <description>To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children</description>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_label>local infiltration of the trocar wounds</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age betwween 3 and 15 years&#xD;
&#xD;
          -  Weight &lt; or = 50 kg&#xD;
&#xD;
          -  indicaction of coelioscopic appendicectomy&#xD;
&#xD;
          -  ASA 1,2 or 3&#xD;
&#xD;
          -  consent of the children and the holder of parental autority&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age&lt;3 years or &gt; 15years or weight &gt; 50kg&#xD;
&#xD;
          -  refusal of the children and the holder of parental autority&#xD;
&#xD;
          -  ASA 4&#xD;
&#xD;
          -  Peritonitis&#xD;
&#xD;
          -  Patients with long term morphinic traitment&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Hepato-cellular insuffisiancy&#xD;
&#xD;
          -  local anesthesia allergy or nalbuphine allergy&#xD;
&#xD;
          -  coagulation abnomrmality&#xD;
&#xD;
          -  exclusion of health insurance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amélie JURINE, Doctor</last_name>
    <phone>0033381669403</phone>
    <email>ajurine@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Besancon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amélie JURINE, Doctor</last_name>
      <phone>+33381669403</phone>
      <email>ajurine@chu-besancon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Appendicectomy</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>infiltration</keyword>
  <keyword>TAP block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

